neuroendocrine tumors
Showing 1 - 25 of 281
Neuroendocrine Tumors Trial in Innsbruck (68Ga-DOTA-MGS5)
Completed
- Neuroendocrine Tumors
-
Innsbruck, AustriaDepartment of Nuclear Medicine, Medical University of Innsbruck
Nov 24, 2023
Neuroendocrine Tumors, Neuroendocrine Tumor of the Lung, Neuroendocrine Tumor Grade 1 Trial in Iowa City ([212Pb] VMT-a-NET,
Recruiting
- Neuroendocrine Tumors
- +4 more
- [212Pb] VMT-α-NET
- [203Pb] VMT-α-NET SPECT/CT
-
Iowa City, IowaHolden Comprehensive Cancer Center at the University of Iowa
Nov 30, 2023
Clinical Relevance of Salvage Treatment for Colorectal
Completed
- Rectal Neoplasms
- Neuroendocrine Tumors
- salvage treatment
- (no location specified)
Nov 16, 2023
Neuroendocrine Tumors Trial in Hyderabad (Endoscopic submucosal dissection, EFTR)
Recruiting
- Neuroendocrine Tumors
- Endoscopic submucosal dissection
- EFTR
-
Hyderabad, Telangana, IndiaAsian institute of Gastroenterology
Nov 11, 2023
Neuroendocrine Tumors, Somatostatin Receptor-positive Neuroendocrine Tumor Trial in Madison (Single Photon Emission Computed
Not yet recruiting
- Neuroendocrine Tumors
- Somatostatin Receptor-positive Neuroendocrine Tumor
- Single Photon Emission Computed Tomography/ Computed Tomography (SPECT/CT)
- +3 more
-
Madison, WisconsinUniversity of Wisconsin - Madison
Nov 2, 2023
Neuroendocrine Tumors Trial in Beijing (Al18F-NOTA-LM3, 68Ga-DOTATATE, 68Ga-NODAGA-LM3)
Recruiting
- Neuroendocrine Tumors
- Al18F-NOTA-LM3
- +2 more
-
Beijing, ChinaPeking Union Medical College Hospital
Sep 20, 2023
Neuroendocrine Carcinomas, Neuroendocrine Tumors, Carcinoma, Neuroendocrine Trial run by the National Cancer Institute (NCI)
Not yet recruiting
- Neuroendocrine Carcinomas
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Sep 22, 2023
Neuroendocrine Tumors Trial in Beijing (Surufatinib Combined With Temozolomide and S-1)
Not yet recruiting
- Neuroendocrine Tumors
- Surufatinib Combined With Temozolomide and S-1
-
Beijing, Beijing, ChinaCancer Institute and Hospital, Chinese Academy of Medical Scienc
Sep 8, 2023
Imaging Features in Invasiveness and Prognosis of Pituitary
Recruiting
- Pituitary Adenoma
- Neuroendocrine Tumors
- diagnosed and treated reasonably according to the clinical guidelines and clinical pathways
-
Guangzhou, Guangdong, Chinaendocrinology department of the first affiliated hospital of Sun
Aug 24, 2023
Neuroendocrine Tumors, NET, Pancreatic Neuroendocrine Tumor Trial in Newport Beach, Denver, Dallas (nab-sirolimus)
Not yet recruiting
- Neuroendocrine Tumors
- +4 more
-
Newport Beach, California
- +2 more
Aug 16, 2023
Evaluation of Study Experiences of Neuroendocrine Tumor Patients
Not yet recruiting
- Neuroendocrine Tumors
-
San Francisco, CaliforniaPower Life Sciences
Jul 21, 2023
Collect Somatuline® Injector Device Preferences of Patients
Not yet recruiting
- Neuroendocrine Tumors
- (no location specified)
Jun 19, 2023
Neuroendocrine Tumors, Lung Neuroendocrine Tumor, Thymus Tumors Trial in France, Italy, Spain (177Lu-edotreotide, Everolimus)
Not yet recruiting
- Neuroendocrine Tumors
- +2 more
-
Bourdeaux, France
- +24 more
Jun 23, 2023
Neuroendocrine Tumors Trial in Beijing (Lutetium[177Lu] Oxodotreotide Injection)
Not yet recruiting
- Neuroendocrine Tumors
- Lutetium[177Lu] Oxodotreotide Injection
-
Beijing, Beijing, ChinaBeijing Cancer Hospital
May 30, 2023
Neuroendocrine Tumors, Peptide Receptor Radionuclide Therapy Trial in Rotterdam (olaparib)
Recruiting
- Neuroendocrine Tumors
- Peptide Receptor Radionuclide Therapy
-
Rotterdam, South Holland, NetherlandsErasmus MC
May 19, 2023
Cancer of Stomach, Oesophageal Cancer, Gastric Cancer Trial in Sydney
Recruiting
- Cancer of Stomach
- +8 more
-
Sydney, New South Wales, AustraliaWestmead Hospital
Mar 26, 2023
Neuroendocrine Tumors, Well-Differentiated Neuroendocrine Carcinoma, High Grade Neuroendocrine Carcinoma, Any Site Trial in San
Not yet recruiting
- Neuroendocrine Tumors
- +2 more
- Lenvatinib
- +2 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Feb 17, 2023
GEP-NET, Neuroendocrine Tumors, Neuroendocrine Carcinoma Trial in Copenhagen (18F-FDG, 64Cu-Dotatate)
Enrolling by invitation
- GEP-NET
- +3 more
-
Copenhagen, DenmarkRigshospitalet
Jan 24, 2023
VHL Pancreatic Neuroendocrine Tumors, Von Hippel-Lindau Disease, Neuroendocrine Tumors Trial run by the National Cancer
Recruiting
- VHL Pancreatic Neuroendocrine Tumors
- +2 more
- 68-Gallium DOTATATE
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 26, 2023
Gastrointestinal Cancer, Colorectal Cancer, Pancreatic Adenocarcinoma Trial in Stanford (Serious Illness Conversation Guide
Terminated
- Gastrointestinal Cancer
- +8 more
- Serious Illness Conversation Guide (SICG)
- Quality of Life (QOL) survey
-
Stanford, CaliforniaStanford Cancer Center
Jan 25, 2023
Neuroendocrine Tumors, Neuroendocrine Carcinoma, Neuroendocrine Cancer Trial in Tampa (Pembrolizumab, Lenvatinib)
Active, not recruiting
- Neuroendocrine Tumors
- +2 more
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Jan 24, 2023
GastroIntestinal Cancer in Children and Adolescents
Active, not recruiting
- Gastrointestinal Cancer
- +6 more
-
Leiden, South-Holland, Netherlands
- +1 more
Jan 11, 2023